- $720.88m
- $2.06bn
- $1.12bn
- 73
- 83
- 63
- 84
Annual income statement for Embecta, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,109 | 1,086 | 1,165 | 1,130 | 1,121 |
| Cost of Revenue | |||||
| Gross Profit | 786 | 763 | 800 | 775 | 750 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 607 | 599 | 673 | 820 | 899 |
| Operating Profit | 502 | 487 | 492 | 310 | 222 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 500 | 486 | 495 | 257 | 106 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 432 | 428 | 415 | 224 | 70.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 432 | 428 | 415 | 224 | 70.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 432 | 428 | 415 | 224 | 70.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 7.47 | 7.4 | 7.17 | 5.51 | 2.32 |
| Dividends per Share |